Hematological Compensation During Treatment of Sickle-Cell Anemia

A Simple Mathematical Model

by Jerry Aroesty, Thomas L. Lincoln, William S. King, Paul F. Morrison


Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback23 pages $20.00 $16.00 20% Web Discount

A simplified mathematical model is proposed for describing steady-state hematologic compensation in the presence of altered red cell properties. The unique pattern of renal oxygen consumption, related to sodium reabsorption and consequently linear in blood flow, is the basis for the simplicity of the model. The model is then applied to the prediction of improvement in the chronic anemia of sickle-cell disease, when red cell life span and oxygen affinity are modified as a result of carbamylation therapy. On this basis, it is predicted that a straight-line relationship exists between hemoglobin concentration and red cell lifetime, and that the reduction in oxygen P-50, as a result of carbamylation, is secondary to red cell lifetime as a factor in determining the reduction in anemia. The predictions are compared with the limited information available from the sodium cyanate clinical trails, and the qualitative agreement between predicted and measured mean values is satisfactory.

This report is part of the RAND Corporation Report series. The report was a product of the RAND Corporation from 1948 to 1993 that represented the principal publication documenting and transmitting RAND's major research findings and final research.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/research-integrity.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.